A carregar...
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI: A Meta-Analysis
CONTENT: Clopidogrel, one of the most commonly prescribed medications, is a pro-drug requiring CYP450 biotransformation. Data suggest its pharmacologic effect varies based on CYP2C19 genotype, but there is uncertainty regarding the clinical risk imparted by specific genotypes. OBJECTIVE: In patients...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3048820/ https://ncbi.nlm.nih.gov/pubmed/20978260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2010.1543 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|